Leeds Teaching Hospitals NHS

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Bladder cancer1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Lung cancer1 trial
• Mantle cell lymphoma1 trial
• Multiple myeloma1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Pharmacyclics Switzerland GmbH1 trial
• Summit Therapeutics1 trial

Running trials

• Active, not recruiting

  Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

  NCT05899608· Phase 3· Summit Therapeutics· Source

• Active, not recruiting

  Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  NCT03229200· Phase 4· Pharmacyclics Switzerland GmbH· Source